🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anna Beth Parlier‐Ahmad

Virginia Commonwealth University

ORCID: 0000-0002-6862-9548

Also affiliated with Michigan Medicine, Mental Illness Research, Education and Clinical Centers

MedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program”.

Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.108200

N/A

0DataRank · unranked

25 citations

Anna Beth Parlier‐Ahmad, Julia Brechbiel, Leila Z. Islam, Caitlin E. Martin, Jaclyn S. Sadicario

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal(2021)10.1186/s12954-021-00553-w

N/A

0DataRank · unranked

21 citations

Mishka Terplan, Dace S. Svikis, Laura Peyton Ellis, Caitlin E. Martin, Anna Beth Parlier‐Ahmad

Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108506

N/A

0DataRank · unranked

17 citations

Anna Beth Parlier‐Ahmad, Caitlin E. Martin, Lori Beck

Development and clinical feasibility study of a brief version of an addiction‐focused phenotyping battery in females receiving buprenorphine for opioid use disorder

Brain and Behavior(2023)10.1002/brb3.3128

N/A

0DataRank · unranked

5 citations

Michelle Eglovitch, Catherine Legge, Lori Keyser‐Marcus, James M. Bjork, Amanda Adams +4 more

Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder

PLoS ONE(2024)10.1371/journal.pone.0304461

N/A

0DataRank · unranked

10 citations

Michelle Eglovitch, Anna Beth Parlier‐Ahmad, Joseph M. Dzierzewski, Morgan H. James, James M. Bjork +3 more

Sex and Gender Differences in Weight-Related Biopsychosocial Factors Among Adults Receiving Buprenorphine for Opioid Use Disorder

Substance Use &amp Addiction Journal(2024)10.1177/29767342241303220

N/A

0DataRank · unranked

1 citations

Taylor A. Ochalek, Melanie K. Bean, Susan Wolver, Salvatore Carbone, Leila Z. Islam +3 more

Neurofunction and Insomnia Symptoms Among Women in Treatment for Opioid Use Disorder

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110678

N/A

0DataRank · unranked

0 citations

Michelle Eglovitch, Anna Beth Parlier‐Ahmad, Jospeh Dzierewski, F. Gerard Moeller, Caitlin E. Martin +1 more